Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Observational × pembrolizumab × Clear all

Status

Sponsor Class

OTHER 35 INDUSTRY 6 UNKNOWN 1 OTHER_GOV 1 INDIV 1

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Head and Neck Neoplasms 1

Interventions

pembrolizumab 1 palbociclib 1 niraparib 1 Therapeutics 1 Standard of Care 1 Radiotherapy, Adjuvant 1 Radiation 1 Pharmaceutical Preparations 1 Neoadjuvant Therapy 1 Methods 1 Immunotherapy 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04740996 2022-02-07

Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China

ChineseAMS

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡